Company Valuation: Telesis Bio, Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023
Capitalization 1 316.5 35.43 11.96
Change - -88.81% -66.23%
Enterprise Value (EV) 1 251 13.28 27.19
Change - -94.71% 104.79%
P/E ratio -5.05x -0.73x -0.24x
PBR 3.49x 0.76x 50.4x
PEG 0.1x 0x 1.42x
Capitalization / Revenue 28.7x 1.29x 0.43x
EV / Revenue 22.7x 0.48x 0.99x
EV / EBITDA -7.35x -0.3x -0.83x
EV / EBIT -7.16x -0.29x -0.77x
EV / FCF - - -
FCF Yield - - -
Dividend per Share 2 - - -
Rate of return - - -
EPS 2 -38.48 -29.61 -29.56
Distribution rate - - -
Net sales 1 11.04 27.44 27.51
EBITDA 1 -34.17 -44.81 -32.83
EBIT 1 -35.07 -46.48 -35.15
Net income 1 -38.96 -48.47 -47.72
Net Debt 1 -65.48 -22.15 15.22
Reference price 2 194.3998 21.6000 7.1820
Nbr of stocks (in thousands) 1,628 1,640 1,666
Announcement Date 23/03/22 22/03/23 29/03/24
1USD in Million2USD
Estimates

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 39.64K
32.09x5.49x21.76x0.29% 215B
76.29x20.04x46.79x-.--% 204B
43.49x7.06x22.81x0.55% 160B
47.22x7.64x24.94x-.--% 145B
20.67x2.44x11.86x2.35% 56.48B
37.49x7.75x25.65x-.--% 50.02B
32.61x6.19x22.06x0.67% 41.18B
18.66x2.15x12.09x0.17% 38.93B
24.46x6.45x16.7x0.94% 37.39B
Average 37.00x 7.25x 22.74x 0.55% 94.75B
Weighted average by Cap. 44.61x 9.08x 26.84x 0.37%
See all sector valuations

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. TBIO Stock
  4. Valuation Telesis Bio, Inc.